Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin prophylaxis after lower third molar removal
RBR-9d26qz7Phase 2Completed
- Sponsor
- Obras Sociais e Educacionais de Luz
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of amoxicillin and Placebo-COD Research Private Ltd in Impacted lower third molar (4 arms), sponsored by Obras Sociais e Educacionais de Luz. Primary endpoints: Pain after surgery and Infection symptoms after surgery. Started Mar 2024; status: completed.
02
Drugs
amoxicillinPlacebo-COD Research Private Ltd
03
Conditions
Impacted lower third molar
Beyond the preview
Go deeper on RBR-9d26qz7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9d26qz7.